Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori
Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
We aimed to (1) compare the efficacy of genotypic resistance guided sequential therapy vs.
susceptibility testing guided therapy in the first-line therapy (2) assess the long term
impact of eradication therapy on the antibiotic resistance and microbiota of the gut flora
and the metabolic factors in this multi-center, open labeled trial